Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis (Q83306839)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Yuki Tanaka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Shinji Kume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Shin-ichi Araki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Keiji Isshiki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Masami Chin-Kanasaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Masayoshi Sakaguchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Toshiro Sugimoto

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Daisuke Koya

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Masakazu Haneda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Atsunori Kashiwagi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Hiroshi Maegawa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Takashi Uzu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

26 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

871-882

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21270762%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2010.530

21 January 2020

exact match

0 references

cites work

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Cellular lipid metabolism and the role of lipids in progressive renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Lipotoxicity: when tissues overeat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Diseases of liporegulation: new perspective on obesity and related disorders

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Contribution of proteinuria to progressive renal injury: consequences of tubular uptake of fatty acid bearing albumin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Structural and functional changes in the kidneys of high-fat diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Peroxisome proliferator-activated receptor-alpha activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Pathophysiology of disease progression in proteinuric nephropathies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

PPARalpha protects proximal tubular cells from acute fatty acid toxicity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Deletion of IL-18 receptor ameliorates renal injury in bovine serum albumin-induced glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Involvement of glomerular SREBP-1c in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Rosiglitazone and fenofibrate improve insulin sensitivity of pre-diabetic OLETF rats by reducing malonyl-CoA levels in the liver and skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021

Involvement of ERK pathway in albumin-induced MCP-1 expression in mouse proximal tubular cells.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.530

7 January 2021